MR characterization of focal liver lesions: Pearls and pitfalls

Magnetic Resonance Imaging Clinics of North America

Volumn 22, Issue 3, 2014, Pages 295-313

  Siegelman, Evan S ^a   Chauhan, Anil ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Focal nodular hyperplasia; Hepatic adenoma; Hepatic steatosis; Hepatocellular carcinoma; Magnetic resonance imaging; Siderotic regenerative nodules

Indexed keywords

ETHIODIZED OIL; GADOXETIC ACID; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; IODINATED POPPYSEED OIL; ORAL CONTRACEPTIVE AGENT; CONTRAST MEDIUM;

ADENOCARCINOMA; ANGIOMYOLIPOMA; CHEMOEMBOLIZATION; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DRUG WITHDRAWAL; FATTY LIVER; FOCAL LIVER LESION; GERM CELL TUMOR; HEPATIC ANGIOMYOLIPOMA; HUMAN; KIDNEY CARCINOMA; LIPOSARCOMA; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CYST; LIVER DISEASE; LIVER FOCAL NODULAR HYPERPLASIA; LIVER HEMANGIOMA; LIVER HEMORRHAGE; LIVER METASTASIS; LIVER NODULE; MUCINOUS ADENOCARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SIDEROTIC REGENERATIVE NODULE; SPLEEN; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS; PATHOLOGY; PROCEDURES;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING;

EID: 84905404457     PISSN: 10649689     EISSN: 15579786     Source Type: Journal    
DOI: 10.1016/j.mric.2014.04.005     Document Type: Review

References (105)

1. Fisher A.R., Siegelman E.S. Magnetic resonance imaging techniques. Clin Liver Dis 2002, 6:53-72. vi.
2. Furlan A., Marin D., Bae K.T., et al. Focal liver lesions hyperintense on T1-weighted magnetic resonance images. Semin Ultrasound CT MR 2009, 30:436-449.
3. Mitchell D.G., Burk D.L., Vinitski S., et al. The biophysical basis of tissue contrast in extracranial MR imaging. AJR Am J Roentgenol 1987, 149:831-837.
4. Goldberg M.A., Hahn P.F., Saini S., et al. Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions. AJR Am J Roentgenol 1993, 160:1011-1017.
5. Cristiano A., Dietrich A., Spina J.C., et al. Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updates Surg 2014, 66(1):9-21.
6. Maillette de Buy Wenniger L., Terpstra V., Beuers U. Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg 2010, 27:24-31.
7. Wanless I.R., Mawdsley C., Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985, 5:1194-1200.
8. Vilgrain V., Uzan F., Brancatelli G., et al. Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis. Radiology 2003, 229:75-79.
9. Ramirez-Fuentes C., Marti-Bonmati L., Torregrosa A., et al. Variations in the size of focal nodular hyperplasia on magnetic resonance imaging. Radiologia 2012, 55(6):499-504.
10. Rifai K., Mix H., Krusche S., et al. No evidence of substantial growth progression or complications of large focal nodular hyperplasia during pregnancy. Scand J Gastroenterol 2013, 48:88-92.
11. Halankar J.A., Kim T.K., Jang H.J., et al. Understanding the natural history of focal nodular hyperplasia in the liver with MRI. Indian J Radiol Imaging 2012, 22:116-120.
12. Imkie M., Myers S.A., Li Y., et al. Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases. JReprod Med 2005, 50:633-637.
13. Haubert L., Yearsley M., Bloomston M. Hepatocellular carcinoma arising within focal nodular hyperplasia. Am Surg 2010, 76:335-336.
14. Nahm C.B., Ng K., Lockie P., et al. Focal nodular hyperplasia-a review of myths and truths. J Gastrointest Surg 2011, 15:2275-2283.
15. Lebedis C., Luna A., Soto J.A. Use of magnetic resonance imaging contrast agents in the liver and biliary tract. Magn Reson Imaging Clin N Am 2012, 20:715-737.
16. Mortele K.J., Praet M., Van Vlierberghe H., et al. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI. Abdom Imaging 2002, 27:700-707.
17. Stanley G., Jeffrey R.B., Feliz B. CT findings and histopathology of intratumoral steatosis in focal nodular hyperplasia: case report and review of the literature. JComput Assist Tomogr 2002, 26:815-817.
18. Basaran C., Karcaaltincaba M., Akata D., et al. Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI. AJR Am J Roentgenol 2005, 184:1103-1110.
19. Gupta R.T., Iseman C.M., Leyendecker J.R., et al. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium. AJR Am J Roentgenol 2012, 199:35-43.
20. Morana G., Grazioli L., Kirchin M.A., et al. Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration. Invest Radiol 2011, 46:225-239.
21. Bieze M., van den Esschert J.W., Nio C.Y., et al. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 2012, 199:26-34.
22. Mohajer K., Frydrychowicz A., Robbins J.B., et al. Characterization of hepatic adenoma and focal nodular hyperplasia with gadoxetic acid. JMagn Reson Imaging 2012, 36:686-696.
23. Grazioli L., Bondioni M.P., Haradome H., et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 2012, 262:520-529.
24. Purysko A.S., Remer E.M., Coppa C.P., et al. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. AJR Am J Roentgenol 2012, 198:115-123.
25. An H.S., Park H.S., Kim Y.J., et al. Focal nodular hyperplasia: characterisation at gadoxetic acid-enhanced MRI and diffusion-weighted MRI. Br J Radiol 2013, 86:20130299.
26. Karam A.R., Shankar S., Surapaneni P., et al. Focal nodular hyperplasia: central scar enhancement pattern using gadoxetate disodium. JMagn Reson Imaging 2010, 32:341-344.
27. Agnello F., Ronot M., Valla D.C., et al. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology 2012, 262:511-519.
28. Katabathina V.S., Menias C.O., Shanbhogue A.K., et al. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics 2011, 31:1529-1543.
29. van Aalten S.M., Thomeer M.G., Terkivatan T., et al. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 2011, 261:172-181.
30. Balabaud C., Al-Rabih W.R., Chen P.J., et al. Focal nodular hyperplasia and hepatocellular adenoma around the world viewed through the scope of the immunopathological classification. Int J Hepatol 2013, 2013:268625.
31. Shanbhogue A., Shah S.N., Zaheer A., et al. Hepatocellular adenomas: current update on genetics, taxonomy, and management. JComput Assist Tomogr 2011, 35:159-166.
32. Ronot M., Bahrami S., Calderaro J., et al. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 2011, 53:1182-1191.
33. Deneve J.L., Pawlik T.M., Cunningham S., et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2009, 16:640-648.
34. Bioulac-Sage P., Laumonier H., Couchy G., et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009, 50:481-489.
35. Karkar A.M., Tang L.H., Kashikar N.D., et al. Management of hepatocellular adenoma: comparison of resection, embolization and observation. HPB (Oxford) 2013, 15:235-243.
36. Bunchorntavakul C., Bahirwani R., Drazek D., et al. Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther 2011, 34:664-674.
37. Rebouissou S., Bioulac-Sage P., Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. JHepatol 2008, 48:163-170.
38. Flejou J.F., Barge J., Menu Y., et al. Liver adenomatosis. An entity distinct from liver adenoma?. Gastroenterology 1985, 89:1132-1138.
39. Lewin M., Handra-Luca A., Arrive L., et al. Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. Radiology 2006, 241:433-440.
40. Grazioli L., Federle M.P., Ichikawa T., et al. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology 2000, 216:395-402.
41. Furlan A., van der Windt D.J., Nalesnik M.A., et al. Multiple hepatic adenomas associated with liver steatosis at CT and MRI: a case-control study. AJR Am J Roentgenol 2008, 191:1430-1435.
42. Vetelainen R., Erdogan D., de Graaf W., et al. Liver adenomatosis: re-evaluation of aetiology and management. Liver Int 2008, 28:499-508.
43. Chiche L., Dao T., Salame E., et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 2000, 231:74-81.
44. Han J., van den Heuvel M.C., Kusano H., et al. How normal is the liver in which the inflammatory type hepatocellular adenoma develops?. Int J Hepatol 2012, 2012:805621.
45. Bradley W.G. MR appearance of hemorrhage in the brain. Radiology 1993, 189:15-26.
46. Casillas V.J., Amendola M.A., Gascue A., et al. Imaging of nontraumatic hemorrhagic hepatic lesions. Radiographics 2000, 20:367-378.
47. Enochs W.S., Petherick P., Bogdanova A., et al. Paramagnetic metal scavenging by melanin: MR imaging. Radiology 1997, 204:417-423.
48. Sofue K., Tateishi U., Tsurusaki M., et al. MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT. Eur J Radiol 2012, 81:714-718.
49. Lee C.H., Braga L., de Campos R.O., et al. Hepatic tumor response evaluation by MRI. NMR Biomed 2011, 24:721-733.
50. Mathieu D., Paret M., Mahfouz A.E., et al. Hyperintense benign liver lesions on spin-echo T1-weighted MR images: pathologic correlations. Abdom Imaging 1997, 22:410-417.
51. Mortele K.J., Peters H.E. Multimodality imaging of common and uncommon cystic focal liver lesions. Semin Ultrasound CT MR 2009, 30:368-386.
52. Martin D.R., Kalb B., Sarmiento J.M., et al. Giant and complicated variants of cystic bile duct hamartomas of the liver: MRI findings and pathological correlations. JMagn Reson Imaging 2010, 31:903-911.
53. Siegelman E.S. Adrenal MRI: techniques and clinical applications. JMagn Reson Imaging 2012, 36:272-285.
54. Tsushima Y., Dean P.B. Characterization of adrenal masses with chemical shift MR imaging: how to select echo times. Radiology 1995, 195:285-286.
55. Boll D.T., Merkle E.M. Imaging at higher magnetic fields: 3 T versus 1.5 T. Magn Reson Imaging Clin N Am 2010, 18:549-564. xi-xii.
56. Purysko A.S., Remer E.M., Coppa C.P., et al. LI-RADS: a case-based review of the new categorization of liver findings in patients with end-stage liver disease. Radiographics 2012, 32:1977-1995.
57. Yu J.S., Chung J.J., Kim J.H., et al. Fat-containing nodules in the cirrhotic liver: chemical shift MRI features and clinical implications. AJR Am J Roentgenol 2007, 188:1009-1016.
58. Siripongsakun S., Lee J.K., Raman S.S., et al. MRI detection of intratumoral fat in hepatocellular carcinoma: potential biomarker for a more favorable prognosis. AJR Am J Roentgenol 2012, 199:1018-1025.
59. Kadoya M., Matsui O., Takashima T., et al. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 1992, 183:819-825.
60. Rebouissou S., Imbeaud S., Balabaud C., et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. JBiol Chem 2007, 282:14437-14446.
61. Ronot M., Paradis V., Duran R., et al. MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol 2013, 23:914-923.
62. Siegelman E.S., Rosen M.A. Imaging of hepatic steatosis. Semin Liver Dis 2001, 21:71-80.
63. Robinson P.J. The effects of cancer chemotherapy on liver imaging. Eur Radiol 2009, 19:1752-1762.
64. Karcaaltincaba M., Akhan O. Imaging of hepatic steatosis and fatty sparing. Eur J Radiol 2007, 61:33-43.
65. Ichikawa T., Oh I.S., Kaira K., et al. Education and imaging. Hepatobiliary and pancreatic: multifocal nodular hepatic steatosis associated with the metabolic syndrome. JGastroenterol Hepatol 2007, 22:1693.
66. Kroncke T.J., Taupitz M., Kivelitz D., et al. Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT: imaging findings and diagnosis using MR imaging. Eur Radiol 2000, 10:1095-1100.
67. de Bazelaire C.M., Duhamel G.D., Rofsky N.M., et al. MR imaging relaxation times of abdominal and pelvic tissues measured invivo at 3.0 T: preliminary results. Radiology 2004, 230:652-659.
68. Outwater E.K., Bhatia M., Siegelman E.S., et al. Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology 1997, 205:103-107.
69. Shinozaki K., Yoshimitsu K., Honda H., et al. Metastatic adrenal tumor from clear-cell renal cell carcinoma: a pitfall of chemical shift MR imaging. Abdom Imaging 2001, 26:439-442.
70. Carucci L.R., Siegelman E.S., Feldman M.D. Pancreatic metastasis from clear cell renal carcinoma: diagnosis with chemical shift MRI. JComput Assist Tomogr 1999, 23:934-936.
71. Prakash M., Vyas S., Shanbhogue A.K., et al. Case report: fat-containing liver metastases from retroperitoneal liposarcoma. Indian J Radiol Imaging 2008, 18:230-231.
72. Prasad S.R., Wang H., Rosas H., et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. Radiographics 2005, 25:321-331.
73. Fan Q., Huang H., Lian L., et al. Characteristics, diagnosis and treatment of hepatic metastasis of pure immature ovarian teratoma. Chin Med J (Engl) 2001, 114:506-509.
74. Fisher A., Siegelman E.S. Body MR techniques and MR of the liver. Body MR 2005, 1-62. Elsevier, Philadelphia.
75. Karlo C., Leschka S., Dettmer M., et al. Hepatic teratoma and peritoneal gliomatosis: a case report. Cases J 2009, 2:9302.
76. Kolbeck K.J. Lipiodol= Ethiodol. JVasc Interv Radiol 2011, 22:419-420.
77. Monsky W.L., Kim I., Loh S., et al. Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization. AJR Am J Roentgenol 2010, 195:1220-1230.
78. Yang X., Li A., Wu M. Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases. Med Oncol 2013, 30:416.
79. Tsui W.M., Colombari R., Portmann B.C., et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol 1999, 23:34-48.
80. Anysz-Grodzicka A., Pacho R., Grodzicki M., et al. Angiomyolipoma of the liver: analysis of typical features and pitfalls based on own experience and literature. Clin Imaging 2013, 37:320-326.
81. Lee S.J., Kim S.Y., Kim K.W., et al. Hepatic angiomyolipoma with minimal fat, mimicking hepatocellular carcinoma. Clin Mol Hepatol 2012, 18:330-335.
82. Valls C., Iannacconne R., Alba E., et al. Fat in the liver: diagnosis and characterization. Eur Radiol 2006, 16:2292-2308.
83. Pomerantz S., Siegelman E.S. MR imaging of iron depositional disease. Magn Reson Imaging Clin N Am 2002, 10:105-120. vi.
84. Queiroz-Andrade M., Blasbalg R., Ortega C.D., et al. MR imaging findings of iron overload. Radiographics 2009, 29:1575-1589.
85. Dai Y., Zeng M., Li R., et al. Improving detection of siderotic nodules in cirrhotic liver with a multi-breath-hold susceptibility-weighted imaging technique. JMagn Reson Imaging 2011, 34:318-325.
86. Krinsky G.A., Lee V.S., Nguyen M.T., et al. Siderotic nodules in the cirrhotic liver at MR imaging with explant correlation: no increased frequency of dysplastic nodules and hepatocellular carcinoma. Radiology 2001, 218:47-53.
87. Kim M.J., Mitchell D.G., Ito K., et al. Hepatic iron deposition on magnetic resonance imaging: correlation with inflammatory activity. JComput Assist Tomogr 2002, 26:988-993.
88. Mitchell D.G., Rubin R., Siegelman E.S., et al. Hepatocellular carcinoma within siderotic regenerative nodules: appearance as a nodule within a nodule on MR images. Radiology 1991, 178:101-103.
89. Sadek A.G., Mitchell D.G., Siegelman E.S., et al. Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. Radiology 1995, 195:753-756.
90. Ludwig J., Hashimoto E., Porayko M.K., et al. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997, 112:882-888.
91. Siegelman E.S., Mitchell D.G., Semelka R.C. Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology 1996, 199:13-22.
92. Eng S.C., Taylor S.L., Reyes V., et al. Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis. Liver Int 2005, 25:513-517.
93. Cieszanowski A., Szeszkowski W., Golebiowski M., et al. Discrimination of benign from malignant hepatic lesions based on their T2-relaxation times calculated from moderately T2-weighted turbo SE sequence. Eur Radiol 2002, 12:2273-2279.
94. Thomsen C., Josephsen P., Karle H., et al. Determination of T1- and T2-relaxation times in the spleen of patients with splenomegaly. Magn Reson Imaging 1990, 8:39-42.
95. Curvo-Semedo L., Brito J.B., Seco M.F., et al. The hypointense liver lesion on T2-weighted MR images and what it means. Radiographics 2009, 30:e38.
96. Outwater E., Tomaszewski J.E., Daly J.M., et al. Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. Radiology 1991, 180:327-332.
97. Maetani Y., Itoh K., Watanabe C., et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 2001, 176:1499-1507.
98. Hahn P.F., Weissleder R., Stark D.D., et al. MR imaging of focal splenic tumors. AJR Am J Roentgenol 1988, 150:823-827.
99. McFarland E.G., Mayo-Smith W.W., Saini S., et al. Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology 1994, 193:43-47.
100. McNicholas M.M., Saini S., Echeverri J., et al. T2 relaxation times of hypervascular and non-hypervascular liver lesions: do hypervascular lesions mimic haemangiomas on heavily T2-weighted MR images?. Clin Radiol 1996, 51:401-405.
101. Ito K., Mitchell D.G., Outwater E.K., et al. Hepatic lesions: discrimination of nonsolid, benign lesions from solid, malignant lesions with heavily T2-weighted fast spin-echo MR imaging. Radiology 1997, 204:729-737.
102. Hussain S.M., Outwater E.K., Siegelman E.S. Mucinous versus nonmucinous rectal carcinomas: differentiation with MR imaging. Radiology 1999, 213:79-85.
103. Siegelman E.S., Outwater E.K. Tissue characterization in the female pelvis by means of MR imaging. Radiology 1999, 212:5-18.
104. Lacout A., El Hajjam M., Julie C., et al. Liver metastasis of a mucinous colonic carcinoma mimicking a haemangioma in T2-weighted sequences. JMed Imaging Radiat Oncol 2008, 52:580-582.
105. Ueda K., Matsui O., Nobata K., et al. Mucinous carcinoma of the liver mimicking cavernous hemangioma on pre- and postcontrast MR imaging. AJR Am J Roentgenol 1996, 166:468-469.